Effect of praziquantel on serum glucose and insulin levels in normal and hyperglycemic rats

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 4, 1996, Pages 433-435

  El Kashef, Hassan A ^a   Salem, Hatem A ^a   Said, Shehta A ^a   Elmazar, Mohamed M A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

CAS 10238 21 8; CAS 55268 74 1; glibenclamide, pharmacology; glucose, serum levels; insulin, serum levels; praziquantel, pharmacology

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; PRAZIQUANTEL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; GLUCOSE TOLERANCE TEST; GLYBURIDE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PRAZIQUANTEL; RATS; RATS, WISTAR; SCHISTOSOMICIDES;

EID: 0029983073     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Abdel-Wahab, M. F., Schistosomiasis in Egypt, p. 237, CRC Press, Boca Raton, USA (1982)
2. Wegner, D. H. G., Arzneim.-Forsch./Drug Res. 35 (II), 1132 (1984)
3. Leslie, T., Webster, L. T. Jr., in: The Pharmacological Basis of Therapeutics, A. G. Gilman et al. (eds.), pp. 959-977, Macmillan Publ. Co., New York (1990)
4. Owen, O. E., Felig, P., Morgan, A. P., J. Clin. Invest. 48, 574 (1989)
5. Sabbour, M. S., Farid, Z., Infectious Disease, 1st ed., p. 157, Dar Al-Maaref, Cairo, Egypt (1978)
6. Sandstrom, P. E., Sehlin, J., Eur. J. Pharmacol. 147, 403 (1988)
7. Aynsley, G. Alberti, K. G., Diabetologia 9, 34 (1973)
8. Shaheen, A. A., Ebeid, A., Arzneim.-Forsch./Drug Res. 42 (II), 1504 (1992)
9. Trinder, P., J. Clin. Pathol. 22, 246 (1969)
10. Flier, J. S., Kahn, C. R., Roth, J., N. Engl. J. Med. 300, 413 (1979)
11. Haworth, J. C., Dilling, L. A., Am. J. Obstet. Gynecol. 1, 555 (1975)